Durect Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Durect Corporation (DRRX)
Durect Corporation stock price live, this page displays NASDAQ DRRX stock exchange data. View the DRRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Durect Corporation real time stock price chart below.
What Is the Durect Corporation Stock Price Today?
The Durect Corporation stock price today is 1.8600.
What Is the Stock Symbol for Durect Corporation?
The stock symbol for Durect Corporation is ""DRRX.""
What Stock Exchange Does Durect Corporation Trade On?
Durect Corporation is listed and trades on the NASDAQ stock exchange.
Is Durect Corporation a Good Stock to Buy?
Determining whether Durect Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRRX quote. (ISIN: US2666055007)
What Is the Durect Corporation Stock Price Today?
The Durect Corporation stock price today is 1.8600.
What Is the Stock Symbol for Durect Corporation?
The stock symbol for Durect Corporation is ""DRRX.""
What Stock Exchange Does Durect Corporation Trade On?
Durect Corporation is listed and trades on the NASDAQ stock exchange.
Is Durect Corporation a Good Stock to Buy?
Determining whether Durect Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRRX quote. (ISIN: US2666055007)
NASDAQ
Currency in USD
1.8600
+0.0100(+0.54%)
Closed·
After Hours
1.8402-0.0198(-1.06%)
·
Fair Value
An estimate of a Durect's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8500
1.8700
52 wk Range
0.4801
2.6400
DRRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
DRRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Durect's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.85001.8700
52 wk Range
0.48012.6400
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DRRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Durect's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
2.5000
Upside
+34.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Bausch Health to acquire DURECT for $63 million upfront
- Investing.com
Pro - Form 8K Durect Corporation For: 29 July
- Investing.com
- Durect Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Durect Corporation For: 29 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Durect Corporation Company Profile
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company’s lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; PERSERIS, an injectable suspension for the treatment of schizophrenia in adults; and Methydur to treat attention deficit hyperactivity disorder. It has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Durect Corporation Earnings Call Summary for Q4/2024
- Q4 2024 revenue fell to $500,000 from $900,000 YoY; 2024 total revenue dropped to $2M from $2.6M in 2023
- Durect became debt-free after repaying term loan; cash reserves of $12M expected to sustain operations through Q3 2025
- Focus shifts to Larcicosterol for alcohol-associated hepatitis; Phase 3 trial estimated at $20M, exploring funding options
- R&D expenses reduced to $10.4M in 2024 from $29.4M in 2023; SG&A expenses down to $10M from $12.7M
- Analysts set price targets of $5-$8.50, indicating upside potential despite current financial challenges
Last Updated: 26/03/2025, 22:18
Read Full TranscriptCompare DRRX to Peers and Sector
Metrics to compare | DRRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDRRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.9x | −1.4x | −0.5x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | 10.8x | 1.4x | 2.6x | |
Price / LTM Sales | 31.1x | 1.3x | 3.3x | |
Upside (Analyst Target) | 34.4% | 38.5% | 43.5% | |
Fair Value Upside | Unlock | 37.0% | 6.9% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2.5000
(+34.41% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.13 / -0.11
Revenue / Forecast
321.00K / --
People Also Watch
FAQ
What Stock Exchange Does Durect Trade On?
Durect is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Durect?
The stock symbol for Durect is "DRRX."
What Is the Durect Market Cap?
As of today, Durect market cap is 57.74M.
What Is Durect's Earnings Per Share (TTM)?
The Durect EPS (TTM) is -0.48.
From a Technical Analysis Perspective, Is DRRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Durect Stock Split?
Durect has split 1 times.
How Many Employees Does Durect Have?
Durect has 20 employees.
What is the current trading status of Durect (DRRX)?
As of 07 Aug 2025, Durect (DRRX) is trading at a price of 1.86, with a previous close of 1.86. The stock has fluctuated within a day range of 1.85 to 1.87, while its 52-week range spans from 0.48 to 2.64.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.